|Bid||87.90 x 800|
|Ask||89.92 x 900|
|Day's Range||88.17 - 89.79|
|52 Week Range||64.67 - 103.55|
|Beta (3Y Monthly)||1.02|
|PE Ratio (TTM)||17.39|
|Earnings Date||Apr 18, 2019|
|Forward Dividend & Yield||4.56 (5.00%)|
|1y Target Est||89.12|
Pow! A little fear went a long way on Friday, exacerbated by Thursday's surprisingly big advance. When all was said and done, the S&P 500 lost 1.9% on the last trading day of last week. Yet, it's still above all the key moving average lines. Assume nothing.Nokia (NYSE:NOK) did the most damage, losing more than 6% following reports that it was investigating the terms and conditions of a business acquisition made in 2016. Though not likely, any discovery of issues could lead to penalties. DexCom (NASDAQ:DXCM) logged a much bigger loss though, off more than 9% after analysts with Spruce Point suggests DXCM shares could be cut in half as competition within the glucose monitoring system market heats up.Verizon Communications (NYSE:VZ) tried to resist the tide, advancing 2.5% as investors get fired up over its brewing rollout of 5G connectivity.InvestorPlace - Stock Market News, Stock Advice & Trading TipsThere weren't enough names like Verizon to keep the broad market even close to a breakeven on Friday, however.As the new trading week kicks off, it's the stock charts of Twitter (NYSE:TWTR), UnitedHealth Group (NYSE:UNH) and Philip Morris International (NYSE:PM) that are worth some technical scrutiny. Here's why, and what to look for. Philip Morris International (PM)It has been a good run. Philip Morris International shares are up more than 28% from their December low. But the weight of the big gain is starting to bear down on the stock, and it's doing so at the point that's most opportune for the bears. * 7 Beaten-Up Stocks to Buy as They Reverse Course A pullback wouldn't necessarily have to be a permanent condition though, and it's pretty clear where the bulls would regroup if PM shares suffer the setback being flagged here. Click to Enlarge • The make-or-break ceiling is around $92.80, where the stock peaked last week but also peaked in October.• Zooming out to the weekly chart, we can see shares are stochastically overbought and ripe for profit-taking.• While a setback may be in the works, the convergence of the purple 50-day, the gray 100-day and the white 200-day moving average line could readily combine to act as a floor. Twitter (TWTR)For the past several months, the bears have been trying to upend Twitter but have been unable to do it. That has given the stock time to regroup, and even move into a position to stage a full recovery. That's not happened yet, but one or two more good days could do the trick. And, that effort is taking shape with a very encouraging backdrop. Click to Enlarge • The foundation for the renewed bullish effort is the support supplied at $26.30, where shares made a double bottom in the latter part of last year.• But the big buy trigger here is a move above the white 200-day moving average line and above the falling resistance lines that has tagged all the major peals since December. It's plotted in yellow on both stock charts.• Fanning the bullish flames -- at least partially - is the big bearish gap left behind in July. The upper edge of the gap range is just above the $42 mark. UnitedHealth Group (UNH)Finally, in late February UnitedHealth Group gave a second -- and pretty decisive -- selloff that largely confirmed a major downturn was in the works. That panned out as expected, with UNH stock making a few more days of selling.The bulls did push back, but that effort crumbled and turned back into a downtrend right where one would expect. The renewal of the downtrend at the ideal ceiling sets up a third bearish leg that could end up turning into a bigger selloff than the last couple of setbacks have been. Click to Enlarge • The rally effort was stopped and reversed just as the white 200-day moving average line was bumped. That reversal is highlighted on the daily chart.• The big floor from here is around $235, in line with the past two major bottoms UNH has made. That support is plotted with a red dashed line.• The weekly chart puts things in perspective. The three-year advance was amazing, but arguably overcooked. A little more weakness could easily turn into a lot of profit-taking.As of this writing, James Brumley did not hold a position in any of the aforementioned securities. You can learn more about James at his site, jamesbrumley.com, or follow him on Twitter, at @jbrumley. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 A-Rated Stocks to Buy in the Second Quarter * 7 Reasons Why Apple Streaming Won't Move the Needle for Apple Stock * 7 ETFs for a Millennial Portfolio Compare Brokers The post 3 Big Stock Charts for Monday: Twitter, UnitedHealth Group and Philip Morris appeared first on InvestorPlace.
The company said it would deconsolidate RBH from its financial statements, and it cut its full-year 2019 diluted earnings per share forecast to at least $4.90 at prevailing exchange rates, from at least $5.28 in the forecast it made on March 4, shortly after the ruling in Quebec.
Today, Philip Morris International Inc. (PMI) was informed by its Canadian subsidiary, Rothmans, Benson & Hedges Inc. (RBH) that RBH had obtained an initial order from the Ontario Superior Court of Justice granting it protection under the Companies’ Creditors Arrangement Act (CCAA). RBH announced that obtaining creditor protection became necessary following recent developments in two Class Action proceedings in Québec against RBH, Imperial Tobacco Canada Limited, and JTI-Macdonald Corp. (see “The Class Actions & Other Pending Litigation” below for details).
Biogen lost more than a quarter of its value after discontinuing trials on an Alzheimer’s drug. One analyst compared the drop to the time Philip Morris tumbled more than 20%.
Tobacco giant Philip Morris International has teamed up with youth-focused Vice Media to promote vaping, in a move that has alarmed health campaigners. Vice has agreed a deal with PMI to produce sponsored content endorsing ecigarettes, according to two people with direct knowledge of the arrangement. One said the deal would cost the tobacco group £5m and that the campaign was due to start in April.
The Zacks Analyst Blog Highlights: Deutsche Telekom, Fortescue, General Mills, Philip Morris and Southern
BAT, Philip Morris International Inc. and a local unit of Japan Tobacco Inc. are defendants in lawsuits by Canada’s 10 provinces that want to recoup health-care costs linked to the effects of smoking, a move reminiscent of the U.S. in the 1990s. The first of these cases, some of which date back almost two decades, is scheduled to come to trial this year.
OUTSIDE THE BOX Tobacco stocks got a bounce earlier this month on news of the resignation of Food & Drug Administration chief Scott Gottlieb. This made sense because he has had it in for vaping, menthol cigarettes and nicotine levels in cigarettes.
The PMI IMPACT Expert Council reviewed and selected the projects from more than 157 proposals. “The projects announced today stand out for their innovative thinking and systematic approach to addressing the complexities of illegal trade and its links to a broader range of criminal activities,” stated Paul Makin, member of the PMI IMPACT Expert Council. The selected projects will address multiple aspects of illegal trade – ranging from tobacco, alcohol and pharmaceutical products to the trafficking of rare animal species.
The vast majority of our Ultimate Stock-Pickers are not dividend investors. Warren Buffett at Berkshire Hathaway BRK.B has spoken highly of companies that return capital to shareholders and is not against investing in and holding higher-yielding names. As you may recall from our previous dividend-themed articles, when we screen for top dividend-paying stocks among the holdings of our Ultimate Stock-Pickers we try to find the highest-quality names that are currently held with conviction by our top managers.
Will Upward Momentum Continue for Altria and Philip Morris?(Continued from Prior Part)Philip Morris’s valuation multiple As the graph below shows, Philip Morris International’s (PM) valuation multiple has increased since the beginning of 2019.
Will Upward Momentum Continue for Altria and Philip Morris?(Continued from Prior Part)Importance of dividends Dividends smoothen out return volatility for shareholders. Both Altria Group (MO) and Philip Morris International (PM) have a history of
U.S. equities are pausing for breath on Thursday, amid nagging concerns about the fate of U.S.-China trade talks and ongoing woes for Boeing (NYSE:BA) after President Trump grounded the 787 MAX -- becoming the last country to do so after two fatal crashes of similar circumstances in the last five months.The drag on the Dow Jones Industrial Average, of which Boeing is a component, means that index hasn't gone anywhere in over a month. And zooming out further, it hasn't gone anywhere since last summer when the 25,500 level was first crossed in July. * 7 Winning High-Yield Dividend Stocks With Payouts Over 5% As investors wait for action, it's a perfect time to be reminded of the allure of dividend stocks which literally pay you to wait. While large-cap, big-tech growth stocks have been getting all the attention in recent years, there is still a place for value-focused dividend stocks. Here are seven dividend stocks to check out:InvestorPlace - Stock Market News, Stock Advice & Trading Tips Philip Morris International (PM)Philip Morris International (NYSE:PM) pays a dividend yield of 5.1%. On a technical basis, it's in clear uptrend territory: 3.5% above its 20-day moving average, 14.4% above its 50-day average, and 9.8% above its 200-day average. Shares were recently upgraded to buy by analysts at UBS, who are looking for a $101 price target.The company will next report results on April 18 before the bell. Analysts are looking for earnings of $1.02 per share on revenues of $6.8 billion. When the company last reported results on February 7, earnings of $1.25 beat estimates by nine cents on a 9.6% decline in revenues. Altria Group (MO)Shares of Altria (NYSE:MO) pay a dividend yield of 5.7%. The stock is on the move but not yet overextended: While above its 20-day and 50-day moving averages, its still below its 200-day average. * 7 Stocks to Buy With High ESG Momentum The company will next report results on April 25 before the bell. Analysts are looking for earnings of 94 cents per share on revenues of $4.6 billion. When the company last reported on January 31, earnings of 95 cents per share matches estimates on a 1.5% rise in revenues. The Williams Companies (WMB)Shares of The Williams Companies (NYSE:WMB) pay a dividend yield of 5.5%. The stock is above all three of its major moving averages, but remains 13.9% below its prior 52-week high. The energy pipeline play is well positioned to take advantage of the infrastructure shortage limiting the blitz of U.S. shale oil and gas activity.The company will next report results on May 1 after the close. Analysts are looking for earnings of 23 cents per share on revenues of $2.3 billion. When the company last reported on February 13, earnings of 19 cents per share missed estimates by five cents. Weyerhaeuser (WY)Weyerhaeuser (NYSE:WY) shares pay a dividend yield of 5.2%. Shares are above their 20-day and 50-day moving averages, but remain more than 14% below their 200-day average and nearly a third below the prior 52-week high. Shares recently enjoyed an upgrade by analysts at BMO Capital Markets and were initiated with a buy rating by analysts at Seaport Global Securities. * Are These 3 Airline Stocks in for a Smooth Flight or More Turbulence? The company will next report results on April 26 before the bell. Analysts are looking for earnings of 12 cents per share on revenues of $1.7 billion. When the company last reported on February 1, earnings of 10 cents per share missed estimates by two cents on a 10.3% drop in revenues. Seagate (STX)Seagate (NASDAQ:STX) shares pay a dividend yield of 5.3%. The company is quickly closing in on its 200-day moving average. Semiconductor and memory stocks have been perking up in recent weeks on reports of lean inventories across the industry and hopes of a resurgence of demand for digital devices as global manufacturing recovers.The company will next report results on May 1 after the close. Analysts are looking for earnings of 71 cents per share on revenues of $2.3 billion. When the company last reported on February 4, earnings of $1.41 beat estimates by 14 cents on a 6.6% drop in revenues. Invesco (IVZ)Invesco (NYSE:IVZ) shares pay a dividend yield of 6.2%. Shares are above both their 20-day and 50-day moving averages, but are still more than 12% below their 200-day average and more than 40% away from their prior 52-week high. Barclays analysts recently highlighted management's ongoing effort to find $475 million in cost savings, which would provide an earnings tailwind. * 15 Stocks Sitting on Huge Piles of Cash The company will next report results on April 25 before the bell. Analysts are looking for earnings of 49 cents per share on revenues of $861.5 million. When the company last reported on January 30, earnings of 44 cents per share missed estimates by 11 cents on an 8.5% drop in revenues. Nielsen Holdings (NLSN)Nielsen Holdings (NYSE:NLSN) shares pay a dividend yield of 5.2%. Shares are on a roll, above all three of their major moving averages as they close in on their prior 52-week high which remains 22% to the upside. The company is enjoying a lift thanks to the surge of television programming -- both over-the-air, cable, and streaming -- and the need for programmers to get solid audience data to make production decisions. Activist investor Elliott Management recently purchased a stake.The company will next report results on April 25 before the bell. Analysts are looking for earnings of 32 cents per share on revenues of $1.6 billion. When the company last reported on February 28 earnings of 28 cents per share missed estimates by 27 ents on a 5.8% drop in revenues.As of this writing, William Roth held no positions in the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 15 Stocks Sitting on Huge Piles of Cash * The 10 Best Stocks to Buy for the Bull Market's Anniversary * 7 Dividend Stocks With Big Yields Compare Brokers The post 7 Dividend Stocks to Buy Today appeared first on InvestorPlace.
Tobacco stocks recently took a dive on news of the latest Food and Drug Administration (FDA) hire. Investors sold these stocks off as Health and Human Services (HHS) secretary Alex Azar named National Cancer Institute director Ned Sharpless as the interim head of the FDA.Tobacco stocks had initially risen upon news of the resignation of outgoing FDA head Scott Gottlieb. Gottlieb had wanted to lower nicotine levels in cigarettes and ban menthol cigarettes. Now, with Dr. Sharpless in charge, these initiatives could continue to move forward.However, investors should remember that the Surgeon General's report outlining the dangers of smoking came out in 1964. Despite decreased use of the product in the U.S., tobacco stocks have steadily risen in the 55 years since the release of that report. Moreover, hemp legalization, as well as the full legal status of cannabis in several U.S. states could become a source for profit growth.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * The 10 Best Stocks to Buy for the Bull Market's Anniversary Still, no matter the length of Dr. Sharpless's tenure at the FDA, all tobacco stocks will face regulatory challenges. However, by adapting to the regulatory environment and finding new segments of growth, these tobacco stocks can maintain generous dividends and continue offering returns: Altria (MO)Source: Peyri Herrera via Flickr (Modified)As the owner of the popular Marlboro brand, Altria (NYSE:MO) remains one of the more profitable tobacco stocks. Like its peers, MO stock fell upon the news from the FDA. Given the background of Dr. Sharpless, one has to assume he will continue Dr. Gottlieb's anti-tobacco initiatives.However, I think this will serve as a non-event for MO stock. The equity recovered its post-announcement losses in a day. In my view, that recovery signals that the hire of Dr. Sharpless means the status quo, not further bad news.Profit estimates for this year have fallen from $4.32 per share 90 days ago to $4.20 per share today. However, that is old news. Investors also know that profit growth will average 6.91% per year, over the next five years. While this represents a slowdown from the 11.51% per year growth rate over the previous five years, investors have also priced that news into MO.Meanwhile, the company continues to build new sources of revenue. Altria invested $12.8 billion in electronic cigarette maker Juul. Moreover, with the company's $1.8 billion investment in Cronos (NASDAQ:CRON), cannabis can also serve as a new source of revenue.Even if anti-tobacco initiatives harm their traditional business, Altria appears to keep increasing profits and payouts. The dividend yield currently stands at about 5.7%. This payout has risen for ten straight years. Moreover, investors who have held the stock since 2003 and reinvested the dividends now earn back their original investment every year in dividends alone. Hence, while the tenure of Dr. Sharpless could affect stock price growth, MO stock is still likely to continue to deliver returns. Imperial Brands (IMBBY)Source: Shutterstock Those wanting tobacco stocks free from a harsh U.S. regulatory environment pay turn to Imperial Brands (OTCMKTS:IMBBY). This seller of the popular Kool and Winston brands sells tobacco products in more than 160 countries. It also leads the world in fine-cut tobacco products and serves as the leading seller of cigars in several of its markets.The U.S. accounted for about 21.7% of its revenue in 2018. Although this leaves most of the business outside the confines of the FDA regulation, IMBBY stock has suffered like most tobacco stocks as consumers around the world have increasingly turned away from tobacco.Interestingly, the company itself has followed this anti-tobacco trend. In 2016, IMBBY changed its name from Imperial Tobacco to Imperial Brands to reflect all of its lines of business. Like its major peers, Imperial has moved into e-cigarettes. IMBBY has also entered the cannabis business. In 2018, its subsidiary Imperial Brands Ventures invested in Oxford Cannabinoid. This gave Imperial a stake in the market of cannabis-based medicines.Moreover, Imperial has outperformed its peers in one area--dividends. This year's payout of $3.44 per share takes the yield to about 10%. Although the company cut this payout in 2016, it has risen over time. * 10 Dividend Stock Winners As an equity, IMBBY stock may not see big gains in the near term as slowing tobacco use and FDA regulation weigh on the company. However, the company now seeks to revive its fortunes in cannabis and e-cigarettes. This should leave Imperial Brands well-positioned to continue its generous payouts. Philip Morris International (PM)Source: Shutterstock Of the global tobacco stocks, none stand in a better position to avoid the FDA than Philip Morris (NYSE:PM). This company once acted as the offshore arm of Altria and became a separate firm in 2008. Other than possible issues related to its New York City base of operations, its offshore markets leave the FDA with little power to regulate PM.Philip Morris retains the rights to sell Marlboro and other brands outside of the U.S. However, investors should think of PM stock as more than "non-U.S. Altria." It has also separated itself from other tobacco stocks by stating a desire to leave the tobacco business.The company has invested heavily in its iQOS e-cigarette brand. The company hopes iQOS will satisfy both consumers and regulators to the point that it replaces tobacco. At least so far, PM has also chosen not to enter the cannabis space. CEO Andre Calantzopoulos cited his hopes for iQOS as one reason why.Still, PM stock has behaved like a tobacco equity. Like its peers, it has fallen over the last year. Moreover, it has retained the dividend philosophy of its former parent. PM has increased its payout every year since its founding. This year's dividend of $4.56 per share yields about 5.1%. Predicted growth rates of 5.9% this year and 8.5% in 2020 should help the company fund further payout hikes.It remains unclear whether its iQOS-focused strategy will pay off in the long run. However, the non-U.S. focus protects PM stock from most FDA scrutiny. Moreover, its market positioning and generous dividend should make Philip Morris a long-term winner for income-focused investors.As of this writing, Will Healy did not hold a position in any of the aforementioned stocks. You can follow Will on Twitter at @HealyWriting. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 15 Stocks Sitting on Huge Piles of Cash * The 10 Best Stocks to Buy for the Bull Market's Anniversary * 7 Dividend Stocks With Big Yields Compare Brokers The post 3 Tobacco Stocks That Will Perform Well Despite FDA Regulations appeared first on InvestorPlace.
Will Upward Momentum Continue for Altria and Philip Morris?(Continued from Prior Part)Analysts’ revenue expectations For 2019, analysts are expecting Philip Morris International (PM) to post revenue of $30.68 billion, which represents a rise of
Landmark 6-month study demonstrating that e-cigarette vapors induce significantly lower biological responses associated with cardiovascular and pulmonary diseases compared with cigarette smoke. This first-of-its-kind study evaluated the impact of e-cigarette vapor, with and without nicotine, on the risks of respiratory and cardiovascular disease in a mouse model. These results add to the existing evidence that switching smokers to smoke-free products, which can deliver nicotine with significantly lower levels of toxicants, can be part of a successful tobacco harm reduction strategy for adult smokers worldwide.
Will Upward Momentum Continue for Altria and Philip Morris?(Continued from Prior Part)Analysts’ revenue estimates Analysts expect Altria Group (MO) to post revenue of $19.85 billion in 2019, which represents a rise of 1.1% from $19.63 billion in
Will Upward Momentum Continue for Altria and Philip Morris?(Continued from Prior Part)Altria’s EPS growth Altria Group (MO) posted adjusted EPS of $3.99 in 2018, which represents a rise of 17.7% from $3.39 in 2017. The revenue growth, lower
Our The Timely Ten list represents our top ten current recommendations from among our universe of undervalued blue chip stocks, explains dividend expert Kelley Wright, editor of the industry-leading advisory service, Investment Quality Trends.